WASHINGTON, United States (AFP) — Pfizer is “very close” to applying for an emergency use approval for its Covid-19 vaccine after collecting safety data to submit to US regulators, the company’s CEO said Tuesday, according to a report. The pharmaceutical giant announced last week preliminary results from a late-stage clinical trial showing the injections it had co-developed with Germany’s BioNTech was more than 90 percent effective after the second dose. “We are very close to […]